mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.5 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.035 |
0.5 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |